RESMED INC — Director's Dealing 2016

Jan 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-01-04

Reporting Person: FARRELL PETER C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-04	ResMed Common Stock	M	20000	$25.54	Acquired	367978	Direct
2016-01-04	ResMed Common Stock	S	20000	$52.22	Disposed	347978	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-04	Resmed Stock Option Plan	$25.54	M	20000	Disposed	2016-12-17	ResMed Common Stock (20000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	87776	Indirect
ResMed Common Stock	52204	Indirect

Footnotes

F1: The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.

F2: Represents date options first became exercisable. Options vest ? annually on the anniversary of the grant.

F3: This transaction was executed in multiple trades at prices ranging from $51.85 to $52.71. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F4: Securities held by Larry Poster, Trustee of the Peter C. Farrell Grantor Retained Annuity Trusts.